Upstream Bio Inc
NASDAQ:UPB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Upstream Bio Inc
NASDAQ:UPB
|
US |
|
Precigen Inc
NASDAQ:PGEN
|
US |
|
Telesia SpA
MIL:TLS
|
IT |
|
DBS Group Holdings Ltd
OTC:DBSDF
|
SG |
|
New Sources Energy NV
AEX:NSE
|
NL |
|
Amaero International Ltd
ASX:3DA
|
AU |
Wall Street
Price Targets
UPB Price Targets Summary
Upstream Bio Inc
According to Wall Street analysts, the average 1-year price target for
UPB
is 49.47 USD
with a low forecast of 35.35 USD and a high forecast of 78.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is UPB's stock price target?
Price Target
49.47
USD
According to Wall Street analysts, the average 1-year price target for
UPB
is 49.47 USD
with a low forecast of 35.35 USD and a high forecast of 78.75 USD.
What is Upstream Bio Inc's Revenue forecast?
Projected CAGR
26%
For the last 2 years the
compound annual growth rate for
Upstream Bio Inc's revenue is
10%.
The projected
CAGR
for the next 3 years is
26%.